All lobbying filings

Alpine Group Partners, LLC.

Alpine Group Partners, LLC. filed a Q3 report for Amgen on October 15, 2026, reporting $50,000 in lobbying income.

Lobbying for Amgen

As filed: ALPINE GROUP PARTNERS, LLC. for AMGEN.

All filings by Alpine Group Partners, LLC. · Everything Amgen has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 15, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Proposals related to drug pricing, drug price transparency, PBMs, the 340B program Implementation of the Inflation Reduction Act

Taxation/Internal Revenue Code

International tax developments

Trade (domestic/foreign)

Tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.